Citigroup Has Trimmed Procter And Gamble Co (Call) (PG) Stake By $990.03 Million, Shorts at Lipocine (LPCN) Lowered By 4.96%

June 20, 2017 - By Vivian Currie

Lipocine Incorporated (NASDAQ:LPCN) had a decrease of 4.96% in short interest. LPCN’s SI was 1.96M shares in June as released by FINRA. Its down 4.96% from 2.06 million shares previously. With 126,400 avg volume, 16 days are for Lipocine Incorporated (NASDAQ:LPCN)’s short sellers to cover LPCN’s short positions. The SI to Lipocine Incorporated’s float is 12.16%. About 5.93 million shares traded or 2602.36% up from the average. Lipocine Inc (NASDAQ:LPCN) has declined 54.30% since June 20, 2016 and is downtrending. It has underperformed by 71.00% the S&P500.

Citigroup Inc decreased Procter And Gamble Co (Call) (PG) stake by 91.78% reported in 2016Q4 SEC filing. Citigroup Inc sold 11.79 million shares as Procter And Gamble Co (Call) (PG)’s stock declined 5.32%. The Citigroup Inc holds 1.06 million shares with $88.74M value, down from 12.84 million last quarter. Procter And Gamble Co (Call) now has $230.57 billion valuation. The stock rose 0.10% or $0.09 reaching $89.95. About 1.39M shares traded. Procter & Gamble Co (NYSE:PG) has risen 7.54% since June 20, 2016 and is uptrending. It has underperformed by 9.16% the S&P500.

Citigroup Inc increased Cummins Inc (Put) (NYSE:CMI) stake by 8,000 shares to 108,400 valued at $14.82M in 2016Q4. It also upped Nabors Industries Ltd (NYSE:NBR) stake by 582,959 shares and now owns 722,659 shares. Energy Transfer Prtnrs LP (Put) (NYSE:ETP) was raised too.

Since February 2, 2017, it had 0 insider buys, and 19 selling transactions for $24.25 million activity. Louvet Patrice had sold 3,837 shares worth $333,819 on Thursday, May 4. $334,265 worth of Procter & Gamble Co (NYSE:PG) was sold by Skoufalos Ioannis. Matthew Price had sold 3,833 shares worth $349,706. On Wednesday, February 15 the insider Posada Juan Fernando sold $170,232. TASTAD CAROLYN M had sold 965 shares worth $88,011. On Tuesday, February 28 FergusonMchugh MaryLynn sold $265,847 worth of Procter & Gamble Co (NYSE:PG) or 2,915 shares. On Friday, February 17 Sheppard Valarie L sold $2.13 million worth of Procter & Gamble Co (NYSE:PG) or 23,512 shares.

Investors sentiment decreased to 0.85 in Q4 2016. Its down 0.03, from 0.88 in 2016Q3. It worsened, as 89 investors sold PG shares while 777 reduced holdings. 122 funds opened positions while 614 raised stakes. 1.48 billion shares or 15.87% less from 1.76 billion shares in 2016Q3 were reported. Roundview Ltd Co reported 29,381 shares stake. Counselors Of Maryland Ltd Co holds 0% or 401 shares in its portfolio. Pinnacle Advisory Group Inc invested in 10,155 shares. Alpine Inv Mngmt Ltd Liability Com holds 2,976 shares. 74,087 were accumulated by Argi Invest Services Lc. 4.31M are owned by Independent Franchise Prtn Ltd Liability Partnership. Hl Limited Liability Co invested in 1.36% or 748,855 shares. Provident Commerce stated it has 11,256 shares. Orleans Management Corp La reported 2.02% stake. Kessler Investment Gru Limited Co holds 31,885 shares or 3.22% of its portfolio. France-based Axa has invested 0.53% in Procter & Gamble Co (NYSE:PG). Navellier And Associate owns 0.37% invested in Procter & Gamble Co (NYSE:PG) for 26,412 shares. Financial Bank Of Nova Scotia holds 0.18% or 428,901 shares. Buckingham Inc owns 36,887 shares or 0.77% of their US portfolio. Enterprise Fincl Svcs Corp holds 0.89% or 21,049 shares in its portfolio.

Among 22 analysts covering Proctor & Gamble (NYSE:PG), 10 have Buy rating, 1 Sell and 11 Hold. Therefore 45% are positive. Proctor & Gamble had 48 analyst reports since August 4, 2015 according to SRatingsIntel. B. Riley & Co maintained the shares of PG in report on Wednesday, October 26 with “Buy” rating. The rating was upgraded by Morgan Stanley to “Overweight” on Tuesday, January 26. The rating was maintained by Jefferies with “Buy” on Tuesday, May 30. The firm earned “Neutral” rating on Tuesday, November 17 by Citigroup. The firm earned “Overweight” rating on Thursday, October 29 by Barclays Capital. RBC Capital Markets maintained the stock with “Sector Perform” rating in Tuesday, October 27 report. Zacks downgraded the stock to “Hold” rating in Tuesday, August 4 report. The firm earned “Outperform” rating on Wednesday, October 26 by CLSA. The rating was maintained by Jefferies on Wednesday, April 19 with “Buy”. As per Monday, January 9, the company rating was downgraded by Goldman Sachs.

Analysts await Procter & Gamble Co (NYSE:PG) to report earnings on August, 1. They expect $0.79 EPS, 0.00% or $0.00 from last year’s $0.79 per share. PG’s profit will be $2.03B for 28.47 P/E if the $0.79 EPS becomes a reality. After $0.96 actual EPS reported by Procter & Gamble Co for the previous quarter, Wall Street now forecasts -17.71% negative EPS growth.

Among 5 analysts covering Lipocine Inc (NASDAQ:LPCN), 5 have Buy rating, 0 Sell and 0 Hold. Therefore 100% are positive. Lipocine Inc had 5 analyst reports since July 22, 2015 according to SRatingsIntel. Empire maintained the stock with “Buy” rating in Wednesday, August 12 report. The company was initiated on Wednesday, July 22 by TH Capital. The stock of Lipocine Inc (NASDAQ:LPCN) earned “Buy” rating by Canaccord Genuity on Tuesday, December 20. The rating was initiated by H.C. Wainwright on Friday, October 7 with “Buy”. The company was initiated on Wednesday, July 22 by Roth Capital.

Lipocine Inc. is a specialty pharmaceutical company. The company has market cap of $85.06 million. The Firm is focused on applying its oral drug delivery technology for the development of pharmaceutical products in the area of men’s and women’s health. It currently has negative earnings. The Company’s primary development programs are based on oral delivery solutions for bioavailable drugs.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our daily email newsletter.

Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our free daily email newsletter: